Akums Drugs and Pharmaceuticals IPO Peer Comparison
Akums Drugs and Pharmaceuticals Limited peer comparison with similar listed entities. (As on March 30, 2024)
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|
| Akums Drugs and Pharmaceuticals Limited | -0.28 | -0.28 | 49.59 | | -0.57 | 13.69 | |
| Divi's Laboratories | 60.27 | 60.27 | 511.21 | 74.99 | 11.79 | 7.24 | |
| Suven Pharmaceuticals Limited | 11.80 | 11.80 | 80.56 | 69.54 | 14.64 | 10.19 | |
| Gland Pharma Limited | 46.90 | 46.89 | 483.41 | 42.45 | 8.85 | 4.12 | |
| Torrent Pharmaceuticals Ltd. | 48.94 | 48.94 | 202.57 | 60.20 | 24.15 | 14.54 | |
| Alkem Laboratories Ltd | 150.19 | 150.19 | 862.46 | 34.18 | 17.41 | 5.95 | |
| Eris Lifesciences Ltd | 28.82 | 28.79 | 190.12 | 34.95 | 15.16 | 5.29 | |
| JB Chemicals | 35.66 | 34.85 | 188.37 | 51.38 | 18.90 | 9.51 | |
| Mankind Pharma Limited | 47.75 | 47.68 | 233.73 | 44.65 | 20.43 | 8.80 | |
| Innova Captab Limited | 18.66 | 18.66 | 145.20 | 29.91 | 11.35 | 3.84 | |
Source:
- The closing Price per share is the closing price in NSE as on July 19, 2024.
- P/E is calculated as closing price / diluted EPS
- Face Value per equity share, Revenue for Operations for Fiscal 2024, EPS (Basic), EPS (Diluted), Return on Net Worth (%) and Net Asset Value per Equity Share are sourced from the Industry Report
